MEITAV INVESTMENT HOUSE LTD - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 44 filers reported holding PLURISTEM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
MEITAV INVESTMENT HOUSE LTD ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$131,000
-36.4%
167,5930.0%0.00%
-50.0%
Q2 2022$206,000
-40.6%
167,5930.0%0.00%
-20.0%
Q1 2022$347,000
+41.6%
167,5930.0%0.01%
+25.0%
Q4 2021$245,000
-44.8%
167,5930.0%0.00%
-42.9%
Q3 2021$444,000
-66.6%
167,593
-50.0%
0.01%
-58.8%
Q2 2021$1,328,000
+66.2%
335,186
+100.0%
0.02%
-22.7%
Q1 2021$799,000
-50.2%
167,593
+9.9%
0.02%
-72.5%
Q3 2020$1,605,000
+32.8%
152,438
+11.5%
0.08%
+11.1%
Q2 2020$1,209,000136,7690.07%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Values First Advisors, Inc. 44,549$394,0000.39%
ARK Investment Management 1,168,616$10,331,0000.11%
MEITAV INVESTMENT HOUSE LTD 136,769$1,209,0000.07%
SABBY MANAGEMENT, LLC 29,699$263,0000.05%
ALGERT GLOBAL LLC 15,620$138,0000.05%
Shepherd Financial Partners LLC 16,730$148,0000.04%
Savior LLC 3,393$30,0000.04%
Lehman & Derafelo Financial Resources LLC 10,000$88,0000.03%
FORA Capital, LLC 8,800$78,000,0000.03%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 44,470$393,0000.02%
View complete list of PLURISTEM THERAPEUTICS INC shareholders